All Is Not Lost: Personal Jurisdiction in a Post-BMS World
By Meegan Hollywood and Jonathan Edelman
In this article, Robins Kaplan attorneys Meegan Hollywood and Jonathan Edelman discuss the impact of the Supreme Court's 2017 decision in Bristol-Myers Squibb Co. v. Superior Court of California ("BMS") on antitrust class actions and provide practical guidance for class action practitioners navigating personal jurisdiction challenges arising from BMS.
©2023. Published in Antitrust Magazine Vol. 38, No. 1, Fall 2023. Reprinted with permission. All rights reserved. This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.